Index
1 Market Overview of Targeted Protein Degradation
1.1 Targeted Protein Degradation Market Overview
1.1.1 Targeted Protein Degradation Product Scope
1.1.2 Targeted Protein Degradation Market Status and Outlook
1.2 Global Targeted Protein Degradation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Targeted Protein Degradation Market Size by Region (2018-2029)
1.4 Global Targeted Protein Degradation Historic Market Size by Region (2018-2023)
1.5 Global Targeted Protein Degradation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Targeted Protein Degradation Market Size (2018-2029)
1.6.1 North America Targeted Protein Degradation Market Size (2018-2029)
1.6.2 Europe Targeted Protein Degradation Market Size (2018-2029)
1.6.3 Asia-Pacific Targeted Protein Degradation Market Size (2018-2029)
1.6.4 Latin America Targeted Protein Degradation Market Size (2018-2029)
1.6.5 Middle East & Africa Targeted Protein Degradation Market Size (2018-2029)
2 Targeted Protein Degradation Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Intravenous
2.1.3 Others
2.2 Global Targeted Protein Degradation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Targeted Protein Degradation Historic Market Size by Type (2018-2023)
2.2.2 Global Targeted Protein Degradation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
3 Targeted Protein Degradation Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Research Institute
3.2 Global Targeted Protein Degradation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Targeted Protein Degradation Historic Market Size by Application (2018-2023)
3.2.2 Global Targeted Protein Degradation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
4 Targeted Protein Degradation Competition Analysis by Players
4.1 Global Targeted Protein Degradation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Protein Degradation as of 2022)
4.3 Date of Key Players Enter into Targeted Protein Degradation Market
4.4 Global Top Players Targeted Protein Degradation Headquarters and Area Served
4.5 Key Players Targeted Protein Degradation Product Solution and Service
4.6 Competitive Status
4.6.1 Targeted Protein Degradation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 5AM Venture Management LLC
5.1.1 5AM Venture Management LLC Profile
5.1.2 5AM Venture Management LLC Main Business
5.1.3 5AM Venture Management LLC Targeted Protein Degradation Products, Services and Solutions
5.1.4 5AM Venture Management LLC Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.1.5 5AM Venture Management LLC Recent Developments
5.2 AbbVie Inc
5.2.1 AbbVie Inc Profile
5.2.2 AbbVie Inc Main Business
5.2.3 AbbVie Inc Targeted Protein Degradation Products, Services and Solutions
5.2.4 AbbVie Inc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.2.5 AbbVie Inc Recent Developments
5.3 Almac Group
5.3.1 Almac Group Profile
5.3.2 Almac Group Main Business
5.3.3 Almac Group Targeted Protein Degradation Products, Services and Solutions
5.3.4 Almac Group Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.3.5 Amgen Inc. Recent Developments
5.4 Amgen Inc.
5.4.1 Amgen Inc. Profile
5.4.2 Amgen Inc. Main Business
5.4.3 Amgen Inc. Targeted Protein Degradation Products, Services and Solutions
5.4.4 Amgen Inc. Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.4.5 Amgen Inc. Recent Developments
5.5 Bayer AG
5.5.1 Bayer AG Profile
5.5.2 Bayer AG Main Business
5.5.3 Bayer AG Targeted Protein Degradation Products, Services and Solutions
5.5.4 Bayer AG Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer AG Recent Developments
5.6 Biogen Inc.
5.6.1 Biogen Inc. Profile
5.6.2 Biogen Inc. Main Business
5.6.3 Biogen Inc. Targeted Protein Degradation Products, Services and Solutions
5.6.4 Biogen Inc. Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.6.5 Biogen Inc. Recent Developments
5.7 C4 Therapeutics
5.7.1 C4 Therapeutics Profile
5.7.2 C4 Therapeutics Main Business
5.7.3 C4 Therapeutics Targeted Protein Degradation Products, Services and Solutions
5.7.4 C4 Therapeutics Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.7.5 C4 Therapeutics Recent Developments
5.8 Cosmo Bio USA
5.8.1 Cosmo Bio USA Profile
5.8.2 Cosmo Bio USA Main Business
5.8.3 Cosmo Bio USA Targeted Protein Degradation Products, Services and Solutions
5.8.4 Cosmo Bio USA Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.8.5 Cosmo Bio USA Recent Developments
5.9 Covance Inc
5.9.1 Covance Inc Profile
5.9.2 Covance Inc Main Business
5.9.3 Covance Inc Targeted Protein Degradation Products, Services and Solutions
5.9.4 Covance Inc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.9.5 Covance Inc Recent Developments
5.10 Eli Lilly and Company
5.10.1 Eli Lilly and Company Profile
5.10.2 Eli Lilly and Company Main Business
5.10.3 Eli Lilly and Company Targeted Protein Degradation Products, Services and Solutions
5.10.4 Eli Lilly and Company Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.10.5 Eli Lilly and Company Recent Developments
5.11 Gilead Sciences, Inc
5.11.1 Gilead Sciences, Inc Profile
5.11.2 Gilead Sciences, Inc Main Business
5.11.3 Gilead Sciences, Inc Targeted Protein Degradation Products, Services and Solutions
5.11.4 Gilead Sciences, Inc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.11.5 Gilead Sciences, Inc Recent Developments
5.12 GlaxoSmithKline plc
5.12.1 GlaxoSmithKline plc Profile
5.12.2 GlaxoSmithKline plc Main Business
5.12.3 GlaxoSmithKline plc Targeted Protein Degradation Products, Services and Solutions
5.12.4 GlaxoSmithKline plc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.12.5 GlaxoSmithKline plc Recent Developments
5.13 Merck KGaA
5.13.1 Merck KGaA Profile
5.13.2 Merck KGaA Main Business
5.13.3 Merck KGaA Targeted Protein Degradation Products, Services and Solutions
5.13.4 Merck KGaA Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.13.5 Merck KGaA Recent Developments
5.14 Mission Therapeutics
5.14.1 Mission Therapeutics Profile
5.14.2 Mission Therapeutics Main Business
5.14.3 Mission Therapeutics Targeted Protein Degradation Products, Services and Solutions
5.14.4 Mission Therapeutics Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.14.5 Mission Therapeutics Recent Developments
5.15 Novartis AG
5.15.1 Novartis AG Profile
5.15.2 Novartis AG Main Business
5.15.3 Novartis AG Targeted Protein Degradation Products, Services and Solutions
5.15.4 Novartis AG Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.15.5 Novartis AG Recent Developments
5.16 Pfizer Inc
5.16.1 Pfizer Inc Profile
5.16.2 Pfizer Inc Main Business
5.16.3 Pfizer Inc Targeted Protein Degradation Products, Services and Solutions
5.16.4 Pfizer Inc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.16.5 Pfizer Inc Recent Developments
5.17 Promega
5.17.1 Promega Profile
5.17.2 Promega Main Business
5.17.3 Promega Targeted Protein Degradation Products, Services and Solutions
5.17.4 Promega Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.17.5 Promega Recent Developments
6 North America
6.1 North America Targeted Protein Degradation Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Targeted Protein Degradation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Targeted Protein Degradation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Targeted Protein Degradation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Targeted Protein Degradation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Targeted Protein Degradation Market Dynamics
11.1 Targeted Protein Degradation Industry Trends
11.2 Targeted Protein Degradation Market Drivers
11.3 Targeted Protein Degradation Market Challenges
11.4 Targeted Protein Degradation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List